Previously Treated Advanced-Disease NSCLC KRAS G12C From a Canadian Multi-Institutional Real-World Evidence Database (CARMA)

被引：0

作者：

Zhan, L. J. ^{[1
]}

Barghout, S. ^{[1
]}

Raptis, S. ^{[1
]}

Al-Agha, F. ^{[1
]}

Popovacki, A. ^{[2
]}

Esfahanian, N. ^{[1
]}

Kasymjanova, G. ^{[3
]}

Proulx-Rocray, F. ^{[4
]}

Chan, S. ^{[5
]}

Richardson, M. ^{[6
]}

Brown, M. C.

Patel, D.

Dean, M. L. ^{[7
]}

Navani, V. ^{[7
]}

Moore, E.

Carvery, L. ^{[2
]}

Yan, E.

Cleary-Gosine, J. ^{[2
]}

Gibson, A. J. ^{[7
]}

Hubley, L. ^{[2
]}

Balaratnam, K. ^{[1
]}

Ngo, T. ^{[2
]}

Gill, A. ^{[9
]}

Black, M. ^{[10
]}

Sacher, A. ^{[1
]}

Bradbury, P. A. ^{[1
]}

Shepherd, F. ^{[1
]}

Leighl, N. ^{[1
]}

Cheema, P. ^{[9
]}

Kuruvilla, S. ^{[10
]}

Agulnik, J. ^{[3
]}

Banerji, S. ^{[8
]}

Juergens, R. ^{[5
]}

Blais, N.

Cheung, W. ^{[7
]}

Wheatley-Price, P. ^{[6
]}

Liu, G. ^{[1
]}

Snow, S. ^{[2
]}

机构：

[1] UHN, Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] QEII Hlth Sci Ctr, Halifax, NS, Canada

[3] Jewish Gen Hosp, Montreal, PQ, Canada

[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[5] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada

[6] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada

[7] Tom Baker Canc Clin, Calgary, AB, Canada

[8] CancerCare Manitoba Res Inst, Winnipeg, MB, Canada

[9] William Osler Hlth Syst, Brampton Civic Hosp, Brampton, ON, Canada

[10] London Hlth Sci Ctr, London, ON, Canada

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

KRAS G12C; Advanced NSCLC; Real-World Data;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP12.03-02

引用

页码：S680 / S680

页数：1

共 50 条

[31] The prognostic impact of the KRAS G12C- mutation in non-small cell lung cancer (NSCLC): a real-world analysis
Sun, Lova
Kim, Julia
Patel, Shetal A.
Kang, Yehrim
Pretre, Vincent
Caro, Nydia
Knoll, Stefanie
Caparica, Rafael
Ye, Fen
Reckamp, Karen L.
CANCER RESEARCH, 2023, 83 (07)
[32] Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC
Zhou, Katherine I.
Lin, Chenyu
Tseng, Chin-Lin
Ramnath, Nithya
Dowell, Jonathan E.
Kelley, Michael J.
JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (05):
[33] Efficacy of Sotorasib Versus Standard Chemotherapy plus Immunotherapy in KRAS G12C Mutated Lung Cancer: A Comparative Study Modeling Real-World Data
Haddad, P.
Hammoud, D.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E28 - E28
[34] Real-World Results of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
Cote, Julie
Leblanc, Richard
Chu, Michael P.
McCurdy, Arleigh
Masih-Khan, Esther
Kardjadj, Moustafa
Jimenez-Zepeda, Victor H.
Song, Kevin
Louzada, Martha L.
Mian, Hira S.
White, Darrell
Sebag, Michael
Reiman, Anthony
Stakiw, Julie
Kotb, Rami
Bergstrom, Debra
Aslam, Muhammad
Kaedbey, Rayan
Venner, Christopher P.
Gul, Engin
Reece, Donna E.
BLOOD, 2022, 140
[35] Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
Zhou, Qing
Meng, Xiangjiao
Sun, Longhua
Huang, Dingzhi
Yang, Nong
Yu, Yan
Zhao, Mingfang
Zhuang, Wu
Guo, Renhua
Hu, Yi
Pan, Yueyin
Shan, Jinlu
Sun, Meili
Yuan, Ying
Fan, Yun
Huang, Jianan
Liu, Lian
Chu, Qian
Wang, Xiuwen
Xu, Chongrui
Lin, Jiaxin
Huang, Jingjing
Huang, Mengna
Sun, Jiya
Zhang, Sujie
Zhou, Hui
Wu, Yi-Long
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (12) : 1630 - 1639
[36] Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.
Cui, Wanyuan
Franchini, Fanny
Alexander, Marliese
Officer, Ann
Wong, Hui Li
IJzerman, Maarten J.
Desai, Jayesh
Solomon, Benjamin J.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[37] KROCUS: A phase II study investigating the efficacy and safety of fulzerasib (GFH925) in combination with cetuximab in patients with previously untreated advanced KRAS G12C mutated NSCLC.
Gregorc, Vanesa
Gonzalez-Cao, Maria
Salvagni, Stefania
Koumarianou, Anna
Gil-Bazo, Ignacio
Maio, Michele
Viteri, Santiago
Majem, Margarita
Gutierrez, Vanesa
Caro, Reyes Bernabe
Sanmamed, Miguel F.
Zhu, Huaqiang
Shen, Haige
Wang, Yu
Rosell, Rafael
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA8511 - LBA8511
[38] Real-world effectiveness and safety of sotorasib in patients with KRAS G12C mutated metastatic non-small cell lung cancer (NSCLC): Results of the IFCT-2102 Lung KG12Ci study
Wislez, M.
Mascaux, C.
Cadranel, J.
Thomas, Q.
Ricordel, C.
Swalduz, A.
Pichon, E.
Veillon, R.
Gounant, V.
Bussac, G. Rousseau
Flandin, A-C. Madroszyk
Daniel, C.
Ravoire, M.
Metivier, A-C.
Fournel, P.
Missy, P.
Morin, F.
Guisier, F.
Westeel, V.
ANNALS OF ONCOLOGY, 2023, 34
[39] Treatment patterns and outcomes in KRASG12C-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study
Barghout, Samir H.
Zhan, Luna Jia
Raptis, Starvroula
Al-Agha, Faisal
Esfahanian, Niki
Popovacki, Aimee
Kasymjanova, Goulnar
Proulx-Rocray, Francis
Chan, Sze Wah Samuel
Richardson, Matthew
Brown, M. Catherine
Patel, Devalben
Dean, Michelle Liane
Navani, Vishal
Moore, Erica
Carvery, Lane
Yan, Elizabeth
Goldshtein, Daniel
Cleary-Gosine, Jasmine
Gibson, Amanda J. W.
Hubley, Lynn
Balaratnam, Karmugi
Ngo, Tran
Gill, Azee
Black, Morgan
Sacher, Adrian
Bradbury, Penelope A.
Shepherd, Frances A.
Leighl, Natasha
Cheema, Parneet
Kuruvilla, Sara
Agulnik, Jason
Banerji, Shantanu
Juergens, Rosalyn
Blais, Normand
Cheung, Winson
Wheatley-Price, Paul
Liu, Geoffrey
Snow, Stephanie
LUNG CANCER, 2024, 194
[40] Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
Julian, Cristina
Pal, Navdeep
Gershon, Anda
Evangelista, Marie
Purkey, Hans
Lambert, Peter
Shi, Zhen
Zhang, Qing
BMC CANCER, 2023, 23 (01)

← 1 2 3 4 5 →